Kymera Therapeutics

Kymera Therapeutics Announces Series A to Advance Novel Therapeutic Modality and Develop Innovative Therapies

CAMBRIDGE, Mass., Oct. 30, 2017 /PRNewswire/ — Kymera Therapeutics LLC today announced a $30M Series A Financing round to advance a transformational new therapeutic modality and discover breakthrough medicines for patients with previously untreatable diseases.